Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Neurocrine Bioscience buy Wells Fargo & Company

Neurocrine Bioscience
Start price
€105.55
13.02.26 / 50%
Target price
€147.44
13.02.27
Performance (%)
26.39%
Price
€133.40
17.08.26
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan currently has a performance of 26.39%. This prediction currently runs until 13.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Neurocrine Bioscience -6.615% -6.615%
iShares Core DAX® -0.046% 5.960%
iShares Nasdaq 100 0.922% 3.693%
iShares Nikkei 225® 3.014% 6.638%
iShares S&P 500 -0.359% 2.747%

Comments by Wells_Fargo___Compan for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) 26.39%
Target price 147.438
Change
Ends at 13.02.27

Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Wells Fargo & Company from $180.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat

Wells Fargo & Company 
0
Report Share
13.02.26

Stopped prediction by Wells_Fargo___Compan for Neurocrine Bioscience

buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€149.30
17.07.26
€174.84
17.07.27
-10.65%
17.08.26

Wells Fargo & Company 
17.07.26 50%